The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad

Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.

Saved in:
Bibliographic Details
Main Author: Sandip A Shah
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=189;epage=192;aulast=Shah
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.
ISSN:0971-5851